270 related articles for article (PubMed ID: 33033862)
1. Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma.
Kim B; Kim SS; Cho SW; Cheong JY; Huh J; Kim JK; Lee JH; Ahn HR; Cho HJ
Eur Radiol; 2021 Apr; 31(4):2507-2517. PubMed ID: 33033862
[TBL] [Abstract][Full Text] [Related]
2. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
Cho HJ; Kim B; Kim HJ; Huh J; Kim JK; Lee JH; Seo CW; Ahn HR; Eun JW; Kim SS; Cho SW; Cheong JY
Eur Radiol; 2020 Aug; 30(8):4182-4192. PubMed ID: 32189053
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of Liver Stiffness Measurements Using Magnetic Resonance Elastography in Patients with Compensated Chronic Liver Disease.
Lee DH; Lee JM; Chang W; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
Eur Radiol; 2018 Aug; 28(8):3513-3521. PubMed ID: 29488082
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.
Ichikawa S; Motosugi U; Enomoto N; Onishi H
Eur Radiol; 2019 Feb; 29(2):1013-1021. PubMed ID: 30043162
[TBL] [Abstract][Full Text] [Related]
5. Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma.
Lee DH; Lee JM; Yi NJ; Lee KW; Suh KS; Lee JH; Lee KB; Han JK
Eur Radiol; 2017 Apr; 27(4):1713-1721. PubMed ID: 27456966
[TBL] [Abstract][Full Text] [Related]
6. Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
Cho HJ; Ahn YH; Sim MS; Eun JW; Kim SS; Kim BW; Huh J; Lee JH; Kim JK; Lee B; Cheong JY; Kim B
Gut Liver; 2022 Mar; 16(2):277-289. PubMed ID: 34810297
[TBL] [Abstract][Full Text] [Related]
7. Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib.
Cho HJ; Kim SS; Nam JS; Oh MJ; Kang DR; Kim JK; Lee JH; Kim B; Yang MJ; Hwang JC; Lim SG; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Cytokine; 2017 Jul; 95():118-125. PubMed ID: 28260649
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance elastography as a preoperative assessment for predicting intrahepatic recurrence in patients with hepatocellular carcinoma.
Lee JH; Hwang JA; Gu K; Shin J; Han S; Kim YK
Magn Reson Imaging; 2024 Jun; 109():127-133. PubMed ID: 38513784
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC.
Qayyum A; Hwang KP; Stafford J; Verma A; Maru DM; Sandesh S; Sun J; Pestana RC; Avritscher R; Hassan MM; Amin H; Rashid A; Wistuba II; Ehman RL; Ma J; Kaseb AO
J Immunother Cancer; 2019 Nov; 7(1):329. PubMed ID: 31779702
[TBL] [Abstract][Full Text] [Related]
10. Changes in the neutrophil-to-lymphocyte ratio predict the prognosis of patients with advanced hepatocellular carcinoma treated with sorafenib.
Hong YM; Yoon KT; Hwang TH; Heo J; Woo HY; Cho M
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1250-1255. PubMed ID: 30925530
[TBL] [Abstract][Full Text] [Related]
11. Early effect of
Kennedy P; Lewis S; Bane O; Hectors SJ; Kim E; Schwartz M; Taouli B
Eur Radiol; 2021 Aug; 31(8):5791-5801. PubMed ID: 33475773
[TBL] [Abstract][Full Text] [Related]
12. The value of quantitative MR elastography-based stiffness for assessing the microvascular invasion grade in hepatocellular carcinoma.
Zhang L; Li M; Zhu J; Zhang Y; Xiao Y; Dong M; Zhang L; Wang J
Eur Radiol; 2023 Jun; 33(6):4103-4114. PubMed ID: 36435877
[TBL] [Abstract][Full Text] [Related]
13. Value of MR elastography for the preoperative estimation of liver regeneration capacity in patients with hepatocellular carcinoma.
Jang S; Lee JM; Lee DH; Joo I; Yoon JH; Chang W; Han JK
J Magn Reson Imaging; 2017 Jun; 45(6):1627-1636. PubMed ID: 27859840
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus.
Kumada T; Toyoda H; Yasuda S; Sone Y; Ogawa S; Takeshima K; Tada T; Ito T; Sumida Y; Tanaka J
Clin Transl Gastroenterol; 2021 Apr; 12(4):e00337. PubMed ID: 33888672
[TBL] [Abstract][Full Text] [Related]
15. Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI.
Doemel LA; Chapiro J; Laage Gaupp F; Savic LJ; Kucukkaya AS; Petukhova A; Tefera J; Zeevi T; Lin M; Schlachter T; Jaffe A; Strazzabosco M; Patel T; Stein SM
Eur Radiol; 2021 May; 31(5):2737-2746. PubMed ID: 33123796
[TBL] [Abstract][Full Text] [Related]
16. Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation.
Lee PC; Chiou YY; Chiu NC; Chen PH; Liu CA; Kao WY; Huo TI; Huang YH; Hou MC; Lin HC; Wu JC; Su CW
Sci Rep; 2020 Feb; 10(1):2006. PubMed ID: 32029840
[TBL] [Abstract][Full Text] [Related]
17. 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence.
Wang J; Shan Q; Liu Y; Yang H; Kuang S; He B; Zhang Y; Chen J; Zhang T; Glaser KJ; Zhu C; Chen J; Yin M; Venkatesh SK; Ehman RL
J Magn Reson Imaging; 2019 Mar; 49(3):719-730. PubMed ID: 30260529
[TBL] [Abstract][Full Text] [Related]
18. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis.
Eaton JE; Sen A; Hoodeshenas S; Schleck CD; Harmsen WS; Gores GJ; LaRusso NF; Gossard AA; Lazaridis KN; Venkatesh SK
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1576-1583.e1. PubMed ID: 31683058
[TBL] [Abstract][Full Text] [Related]
19. Performance of magnetic resonance elastography in primary sclerosing cholangitis.
Eaton JE; Dzyubak B; Venkatesh SK; Smyrk TC; Gores GJ; Ehman RL; LaRusso NF; Gossard AA; Lazaridis KN
J Gastroenterol Hepatol; 2016 Jun; 31(6):1184-90. PubMed ID: 26691631
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts.
Yuan G; Xie F; Song Y; Li Q; Li R; Hu X; Zang M; Cheng X; Lu G; Huang J; Fan W; Rong X; Sun J; Chen J
Front Immunol; 2022; 13():868809. PubMed ID: 35757765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]